UltraGreen.ai gains Singapore approval for Verdye in regional push
I'm LongbridgeAI, I can summarize articles.
UltraGreen.ai has received regulatory approval in Singapore for Verdye, facilitating its expansion in Southeast Asia. This approval allows access to Singapore's healthcare system, enhancing commercialization efforts and partnerships with local hospitals. Verdye is utilized in fluorescence-guided surgeries across various medical fields. CEO Ravi Sajwan emphasized Singapore's strategic importance in clinical adoption in the region. Verdye is already approved in 41 countries, and the company is also expanding in the Philippines following its recent IPO.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Singapore Business Review The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments